EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹3,566 Cr | ₹3,449 Cr | ₹2,737 Cr | ₹2,523 Cr | ₹2,942 Cr |
What is the latest Total Non-Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹3,566 Cr |
| Mar2024 | ₹3,449 Cr |
| Mar2023 | ₹2,737 Cr |
| Mar2022 | ₹2,523 Cr |
| Mar2021 | ₹2,942 Cr |
How is Total Non-Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,566 Cr | 3.37 | |
| Mar2024 | ₹3,449 Cr | 26.01 | |
| Mar2023 | ₹2,737 Cr | 8.49 | |
| Mar2022 | ₹2,523 Cr | -14.22 | |
| Mar2021 | ₹2,942 Cr | - | |
Compare Total Non-Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹27,414.3 Cr | 0.8% | -3.1% | 48.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 0.8% |
-3.1% |
48.5% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses